PAPGENE, INC.
BALTIMORE, United States · Founded 2016 · $2.3M raised
- Headquarters
- BALTIMORE, Maryland
- Employees
- 1–10
- Founded
- 2016
- Business Model
- B2B
- Total Funding
- $2.3M
- Last Round
- $2.3M GrantFeb 2016
- Rounds
- 1
About
PapGene is a molecular diagnostics company founded by Johns Hopkins cancer genomics researchers to commercialize genetic cytology tests for early cancer detection. Using cervical fluid from routine Pap tests, the company developed assays to detect ovarian, endometrial, and bladder cancers. PapGene's technology and team evolved into Thrive Earlier Detection Corp., which was acquired by Exact Sciences for $2.15 billion in 2021.
Summary
PAPGENE, INC. is a Biotech company based in BALTIMORE, United States, founded in 2016. It has raised $2.3M in total across 1 round, most recently a $2.3M Grant round in Feb 2016.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Feb 2016
Similar Companies
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...
Avenzo is a San Diego, CA-based biopharma company to in-license and develop the next generation o...
Minneapolis-based clinical stage biotechnology company focused on the development of molecularly ...
One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...
Global contract development and manufacturing organization (CDMO) focused exclusively on sterile ...
Global contract research organization providing comprehensive drug development and laboratory ser...